HIGHFDA DEVICE

LeMaitre Vascular Artegraft Collagen Vascular Grafts Recall 2025: 28 U.S. Units Affected

LeMaitre Vascular recalled 28 Artegraft Collagen Vascular Grafts distributed nationwide in 17 states. The grafts use bovine carotid arteries sourced from a supplier not reviewed by the appropriate regulatory authority. Patients and healthcare providers should stop using the device immediately and contact LeMaitre Vascular for instructions.

Official notice

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DEVICE
Recall date
September 2, 2025
Status
ACTIVE
Severity
8/10

Quick Facts at a Glance

Recall Date
September 2, 2025
Hazard Level
HIGH
Brand
LeMaitre Vascular
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Medical Devices; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
LeMaitre Vascular
Product type
Vascular Graft
Model numbers
AG 616, AG 630, AG 636, AG 640, AG 645, AG 715, AG 730, AG 735 +7 more
Sold at
Multiple Retailers
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    September 2, 2025

  2. Reported by FDA DEVICE

    October 8, 2025

  3. RecallRadar source check

    April 18, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

The bovine carotid arteries used to produce the impacted grafts from affected lots were sourced using raw material from a supplier that had not been reviewed and approved by the appropriate regulatory authority.

What You Should Do

Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact LeMaitre Vascular, Inc. or your healthcare provider for instructions. Notification method: Letter

About This Product

Artegraft Collagen Vascular Grafts are implanted vascular grafts used in vascular surgery. They are designed to replace or repair diseased blood vessels.

Why This Is Dangerous

The issue arises from bovine carotid arteries used in production, sourced from a supplier not reviewed by the appropriate regulatory authority, potentially impacting safety and regulatory compliance.

Industry Context

This recall is not part of a broader industry pattern.

Practical Guidance

How to identify if yours is affected

  1. Review listed model numbers AG 616 through AG 1030.
  2. Check packaging or labeling for the Artegraft Collagen Vascular Graft name and model.
  3. Consult your clinician if you are unsure whether your graft is affected.

Where to find product info

FDA recall page and LeMaitre Vascular instructions. Manufacturer communications and clinical notes with device labeling.

What timeline to expect

Remedies typically follow manufacturer recall instructions; processing times for replacements or refunds vary. No specific timeline provided in this記.

If the manufacturer is unresponsive

  • Document all attempts to contact the manufacturer.
  • Escalate to FDA via MedWatch to report issues with implants or recall process.

How to prevent similar issues

  • Require supplier qualification and regulatory approvals for raw materials before implantation.
  • Verify regulatory compliance documentation for graft materials in future purchases.

Documentation advice

Keep recall notices, model numbers, UDI codes, and any correspondence with the manufacturer and healthcare providers.

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

Model numbers: AG 616, AG 630, AG 636, AG 640, AG 645, AG 715, AG 730, AG 735, AG 740, AG 745, AG 750, AG 830, AG 840, AG 1015, AG 1030. Sold nationwide in the United States (CA, CT, FL, GA, IL, MA, MS, NC, ND, NJ, NY, OK, PA, TN, TX, VA, WA). When sold: Unknown. Price: Unknown.

Reported Incidents

No injuries or incidents have been reported.

Key Facts

  • 15 model numbers listed: AG 616, AG 630, AG 636, AG 640, AG 645, AG 715, AG 730, AG 735, AG 740, AG
  • 745, AG 750, AG 830, AG 840, AG 1015, AG 1030
  • Distributed nationwide in 17 states: CA, CT, FL, GA, IL, MA, MS, NC, ND, NJ, NY, OK, PA, TN, TX, VA,

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Details

Model Numbers
AG 616
AG 630
AG 636
AG 640
AG 645
+10 more
Affected States
ALL
Report Date
October 8, 2025
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
MEDIUM

AvKARE Recalls Rosuvastatin Tablets Due to Dissolution Issues

AvKARE recalled 7,991 cartons of Rosuvastatin Tablets on December 31, 2025. The recall stems from the product being out of specification for dissolution. Consumers should stop using the medication immediately and consult healthcare providers for guidance.

SUN PHARMACEUTICAL INDUSTRIES
Labeling: Not
Read more